1 results match your criteria: "Technical University of Munich (TUM) Rechts der Isar University Hospital[Affiliation]"
Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
World J Urol
May 2024
Department of Urology, School of Medicine and Health, Technical University of Munich (TUM) Rechts der Isar University Hospital, Ismaningerstr. 22, 81675, Munich, Germany.
Purpose: mpMRI is routinely used to stratify the risk of clinically significant prostate cancer (csPCa) in men with elevated PSA values before biopsy. This study aimed to calculate a multivariable risk model incorporating standard risk factors and mpMRI findings for predicting csPCa on subsequent prostate biopsy.
Methods: Data from 677 patients undergoing mpMRI ultrasound fusion biopsy of the prostate at the TUM University Hospital tertiary urological center between 2019 and 2023 were analyzed.